These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10066024)

  • 21. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
    Nozaki K; Onodera O; Takano H; Tsuji S
    Neuroreport; 2001 Oct; 12(15):3357-64. PubMed ID: 11711886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inherited neurodegenerative diseases and transgenic models.
    Price DL; Becher MW; Wong PC; Borchelt DR; Lee MK; Sisodia SS
    Brain Pathol; 1996 Oct; 6(4):467-80. PubMed ID: 8944317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
    Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
    J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal models of Huntington's disease: from basic research on neuronal death to assessment of new therapeutic strategies.
    Brouillet E
    Funct Neurol; 2000; 15(4):239-51. PubMed ID: 11213527
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of transgenic and knock-in mice to study Huntington's disease.
    Hickey MA; Chesselet MF
    Cytogenet Genome Res; 2003; 100(1-4):276-86. PubMed ID: 14526189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expansion of a 27 CAG repeat allele into a symptomatic huntington disease-producing allele.
    Kelly TE; Allinson P; McGlennen RC; Baker J; Bao Y
    Am J Med Genet; 1999 Nov; 87(1):91-2. PubMed ID: 10528258
    [No Abstract]   [Full Text] [Related]  

  • 27. CAG repeat analyses in frozen and formalin-fixed tissues following primer extension preamplification for evaluation of mitotic instability of expanded SCA1 alleles.
    Zühlke C; Hellenbroich Y; Schaaff F; Gehlken U; Wessel K; Schubert T; Cervos-Navarro J; Pickartz H; Schwinger E
    Hum Genet; 1997 Sep; 100(3-4):339-44. PubMed ID: 9272152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The status of SCA1, MJD/SCA3, FRDA, DRPLA and MD triplet containing genes in patients with Huntington disease and healthy controls.
    Keckarevic D; Culjkovic B; Savic D; Stojkovic O; Kostic V; Vukosavic S; Romac S
    J Neurogenet; 2000 Dec; 14(4):257-63. PubMed ID: 11342385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice.
    Clark HB; Orr HT
    J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of repeat-associated non-AUG translation in neurological microsatellite expansion disorders.
    Castelli LM; Huang WP; Lin YH; Chang KY; Hautbergue GM
    Biochem Soc Trans; 2021 Apr; 49(2):775-792. PubMed ID: 33729487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin.
    Hackam AS; Hodgson JG; Singaraja R; Zhang T; Gan L; Gutekunst CA; Hersch SM; Hayden MR
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1047-55. PubMed ID: 10434304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mini-review: spinocerebellar ataxias: an update of SCA genes.
    Trott A; Houenou LJ
    Recent Pat DNA Gene Seq; 2012 Aug; 6(2):115-21. PubMed ID: 22670601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant protein in Huntington disease is resistant to proteolysis in affected brain.
    Dyer RB; McMurray CT
    Nat Genet; 2001 Nov; 29(3):270-8. PubMed ID: 11600884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinocerebellar ataxia type 17 repeat in patients with Huntington's disease-like and ataxia.
    Cellini E; Forleo P; Nacmias B; Tedde A; Bagnoli S; Piacentini S; Sorbi S
    Ann Neurol; 2004 Jul; 56(1):163; author reply 163-4. PubMed ID: 15236416
    [No Abstract]   [Full Text] [Related]  

  • 38. [New insights in the molecular genetics and pathophysiology of hereditary ataxias].
    Bürk K; Klockgether T; Dichgans J
    Nervenarzt; 1999 Jun; 70(6):491-5. PubMed ID: 10412692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyglutamine pathogenesis.
    Ross CA; Wood JD; Schilling G; Peters MF; Nucifora FC; Cooper JK; Sharp AH; Margolis RL; Borchelt DR
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1005-11. PubMed ID: 10434299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
    Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
    Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.